These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
463 related articles for article (PubMed ID: 20032993)
1. Circulating Th17, Th22, and Th1 cells are increased in psoriasis. Kagami S; Rizzo HL; Lee JJ; Koguchi Y; Blauvelt A J Invest Dermatol; 2010 May; 130(5):1373-83. PubMed ID: 20032993 [TBL] [Abstract][Full Text] [Related]
2. T Lauten TH; Elkhatib SK; Natour T; Reed EC; Jojo CN; Case AJ Brain Behav Immun; 2025 Jan; 123():1061-1070. PubMed ID: 39542072 [TBL] [Abstract][Full Text] [Related]
3. Comparison of On-Label Treatment Persistence in Real-World Patients with Psoriatic Arthritis Receiving Guselkumab Versus Subcutaneous Interleukin-17A Inhibitors. Mease PJ; Ferrante SA; Shiff NJ; Fitzgerald TP; Chakravarty SD; Walsh JA Adv Ther; 2024 Dec; ():. PubMed ID: 39621228 [TBL] [Abstract][Full Text] [Related]
4. Comparison of Two Modern Survival Prediction Tools, SORG-MLA and METSSS, in Patients With Symptomatic Long-bone Metastases Who Underwent Local Treatment With Surgery Followed by Radiotherapy and With Radiotherapy Alone. Lee CC; Chen CW; Yen HK; Lin YP; Lai CY; Wang JL; Groot OQ; Janssen SJ; Schwab JH; Hsu FM; Lin WH Clin Orthop Relat Res; 2024 Dec; 482(12):2193-2208. PubMed ID: 39051924 [TBL] [Abstract][Full Text] [Related]
5. Abrocitinib, tralokinumab and upadacitinib for treating moderate-to-severe atopic dermatitis. Edwards SJ; Karner C; Jhita T; Barton S; Marceniuk G; Yiu ZZN; Wittmann M Health Technol Assess; 2024 Jan; 28(4):1-113. PubMed ID: 38343072 [TBL] [Abstract][Full Text] [Related]
6. Interventions for nail psoriasis. de Vries AC; Bogaards NA; Hooft L; Velema M; Pasch M; Lebwohl M; Spuls PI Cochrane Database Syst Rev; 2013 Jan; 2013(1):CD007633. PubMed ID: 23440816 [TBL] [Abstract][Full Text] [Related]
7. Falls prevention interventions for community-dwelling older adults: systematic review and meta-analysis of benefits, harms, and patient values and preferences. Pillay J; Gaudet LA; Saba S; Vandermeer B; Ashiq AR; Wingert A; Hartling L Syst Rev; 2024 Nov; 13(1):289. PubMed ID: 39593159 [TBL] [Abstract][Full Text] [Related]
15. Tissue and circulating levels of IL-17A and FoxP3 Matar AM; Shehata WA; Kora MA; Shendi SS Mol Biochem Parasitol; 2024 Dec; 260():111652. PubMed ID: 39209219 [TBL] [Abstract][Full Text] [Related]
16. A role for T cell-derived interleukin 22 in psoriatic skin inflammation. Boniface K; Guignouard E; Pedretti N; Garcia M; Delwail A; Bernard FX; Nau F; Guillet G; Dagregorio G; Yssel H; Lecron JC; Morel F Clin Exp Immunol; 2007 Dec; 150(3):407-15. PubMed ID: 17900301 [TBL] [Abstract][Full Text] [Related]
17. Analysis of CD161 expression on human CD8+ T cells defines a distinct functional subset with tissue-homing properties. Billerbeck E; Kang YH; Walker L; Lockstone H; Grafmueller S; Fleming V; Flint J; Willberg CB; Bengsch B; Seigel B; Ramamurthy N; Zitzmann N; Barnes EJ; Thevanayagam J; Bhagwanani A; Leslie A; Oo YH; Kollnberger S; Bowness P; Drognitz O; Adams DH; Blum HE; Thimme R; Klenerman P Proc Natl Acad Sci U S A; 2010 Feb; 107(7):3006-11. PubMed ID: 20133607 [TBL] [Abstract][Full Text] [Related]
18. In vivo activated monocytes from the site of inflammation in humans specifically promote Th17 responses. Evans HG; Gullick NJ; Kelly S; Pitzalis C; Lord GM; Kirkham BW; Taams LS Proc Natl Acad Sci U S A; 2009 Apr; 106(15):6232-7. PubMed ID: 19325128 [TBL] [Abstract][Full Text] [Related]
19. The effectiveness of abstinence-based and harm reduction-based interventions in reducing problematic substance use in adults who are experiencing homelessness in high income countries: A systematic review and meta-analysis: A systematic review. O'Leary C; Ralphs R; Stevenson J; Smith A; Harrison J; Kiss Z; Armitage H Campbell Syst Rev; 2024 Jun; 20(2):e1396. PubMed ID: 38645303 [TBL] [Abstract][Full Text] [Related]